Literature DB >> 8296941

Providing medical care to methadone clinic patients: referral vs on-site care.

A Umbricht-Schneiter1, D H Ginn, K M Pabst, G E Bigelow.   

Abstract

OBJECTIVES: Intravenous drug users are at high risk for medical illness, yet many are medically underserved. Most methadone treatment programs have insufficient resources to provide medical care. The purpose of this study was to test the efficacy of providing medical care at a methadone clinic site vs referral to another site.
METHODS: Patients with any of four target medical conditions were randomized into an on-site group offered medical care at the methadone treatment clinic and a referred group offered medical care at a nearby clinic. Entry to treatment and use of medical services were analyzed.
RESULTS: Of 161 intravenous drug users evaluated, 75 (47%) had one or more of the target medical conditions. Fifty-one were randomized. In the on-site group (n = 25), 92% received medical treatment; in the referred group (n = 26), only 35% received treatment.
CONCLUSIONS: Providing medical care at a methadone treatment program site is more effective than the usual referral procedure and is a valuable public health intervention.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8296941      PMCID: PMC1615007          DOI: 10.2105/ajph.84.2.207

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

1.  Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program.

Authors:  P A Selwyn; A R Feingold; A Iezza; M Satyadeo; J Colley; R Torres; J F Shaw
Journal:  Ann Intern Med       Date:  1989-11-01       Impact factor: 25.391

2.  Comparison of chemiluminescent DNA probe to cell culture for the screening of Chlamydia trachomatis in a gynecology clinic population.

Authors:  L J Mercer; D C Robinson; D F Sahm; M J Lawrie; S N Hajj
Journal:  Obstet Gynecol       Date:  1990-07       Impact factor: 7.661

3.  AIDS and addiction in New York City.

Authors:  E Drucker
Journal:  Am J Drug Alcohol Abuse       Date:  1986       Impact factor: 3.829

Review 4.  HIV infection among intravenous drug abusers in the United States and Europe.

Authors:  H W Haverkos
Journal:  NIDA Res Monogr       Date:  1988

5.  Medical students' attitudes toward AIDS, homosexual, and intravenous drug-abusing patients: a re-evaluation in New York City.

Authors:  B J McGrory; D M McDowell; P R Muskin
Journal:  Psychosomatics       Date:  1990       Impact factor: 2.386

6.  Tuberculosis, AIDS, and i.v. drug abuse.

Authors:  R J Lamb; I T Yeh
Journal:  N J Med       Date:  1990-05

7.  Noncompliance in the treatment of endocarditis. The medical staff as co-conspirators.

Authors:  B A Schindler; D Blum; R Malone
Journal:  Gen Hosp Psychiatry       Date:  1988-05       Impact factor: 3.238

8.  Intravenous drug abuse and one academic health center.

Authors:  P E Dans; R M Matricciani; S E Otter; D S Reuland
Journal:  JAMA       Date:  1990-06-20       Impact factor: 56.272

Review 9.  Methadone treatment and acquired immunodeficiency syndrome.

Authors:  J R Cooper
Journal:  JAMA       Date:  1989 Sep 22-29       Impact factor: 56.272

10.  [AIDS epidemiology and prevention in i.v. drug addicts].

Authors:  A Uchtenhagen
Journal:  Soz Praventivmed       Date:  1988
View more
  53 in total

1.  Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?

Authors:  P D Friedmann; T A D'Aunno; L Jin; J A Alexander
Journal:  Health Serv Res       Date:  2000-06       Impact factor: 3.402

2.  On-site primary care and mental health services in outpatient drug abuse treatment units.

Authors:  P D Friedmann; J A Alexander; L Jin; T A D'Aunno
Journal:  J Behav Health Serv Res       Date:  1999-02       Impact factor: 1.505

3.  The impact of managed care on substance abuse treatment services.

Authors:  Todd Olmstead; William D White; Jody Sindelar
Journal:  Health Serv Res       Date:  2004-04       Impact factor: 3.402

4.  Do drug treatment facilities increase clients' exposure to potential neighborhood-level triggers for relapse? A small-area assessment of a large, public treatment system.

Authors:  Jerry O Jacobson
Journal:  J Urban Health       Date:  2006-03       Impact factor: 3.671

5.  Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Hannah K Knudsen; Brian E Bride; G Rush Smith; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-04-25

6.  Hospital- versus community-based syringe exchange: a randomized controlled trial.

Authors:  Carmen L Masson; James L Sorensen; David C Perlman; Michael S Shopshire; Kevin L Delucchi; TeChieh Chen; Karl Sporer; Don Des Jarlais; Sharon M Hall
Journal:  AIDS Educ Prev       Date:  2007-04

Review 7.  Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?

Authors:  Erik W Gunderson; David A Fiellin
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 8.  Mind and body reunited: improving care at the behavioral and primary healthcare interface.

Authors:  Barbara J Mauer; Benjamin G Druss
Journal:  J Behav Health Serv Res       Date:  2009-04-02       Impact factor: 1.505

9.  Changing profile of abused substances by older persons entering treatment.

Authors:  Michelle R Lofwall; Alyson Schuster; Eric C Strain
Journal:  J Nerv Ment Dis       Date:  2008-12       Impact factor: 2.254

10.  Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.

Authors:  Peter D Friedmann; Zhiwei Zhang; James Hendrickson; Michael D Stein; Dean R Gerstein
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.